spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)



Fig. 4. The N terminus and FAT domain of PYK2 are required for PYK2-mediated actin cytoskeleton reorganization. (a) Mapping domains of PYK2 required for actin cytoskeleton reorganization and focal adhesion targeting. Plasmids encoding wild-type PYK2 (A,A') and its deletion mutants including PYK2{Delta}1-88 (B,B'), PYK2{Delta}1-416 (C,C'), PYK2{Delta}1-868 (D,D'), PYK2{Delta}1-902 (E,E') and PYK2{Delta}936-1009 (F,F') were microinjected into Swiss 3T3 cells. The microinjected cells were fixed 2-4 hours after injection and immunostained with antibodies against PYK2 (polyclonal, against PYK2 amino acids 587-988) (A-F) and paxillin (A'-F'). (b) PYK2 and PYK2 mutants and a summary of the phenotypes of Swiss 3T3 cells expressing these mutants. The numbers on the diagrams represent the amino acid residues in PYK2. The proline-rich sequences, Band 4.1, kinase and FAT domains are indicated. The percentage of cytoskeleton reorganizing activity was determined by counting the number of PYK2-expressing cells with podosome-like focal adhesions and dividing by the total number of PYK2-expressing cells. More than 200 injected cells of each construct were counted. The percentage of total PYK2-expressing cells with normal or podosome-like focal adhesion localization of PYK2 is also listed.





Right arrow Return to article